longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Syra Health

SYRA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 123.33, above the reasonable range, cheaper than 1.16% of the time in the past 3 years, and the industry ranks 28/74, the industry Median --.

123.33xP/E
$0.93Stock price
$0.01Earnings per share
123.33xP/E
Stock price$0.93Earnings per share$0.01

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.82x
Typical range
-6.96x–-0.93x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0316293124

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
SYRAUSSyra Health
123.33x--$16.13M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.